Premier Diagnostic Health Services Inc.
CNSX : PDH

Premier Diagnostic Health Services Inc.

October 24, 2014 13:36 ET

Premier Diagnostic Health Services Inc. Announces Securities Issuance

BURNABY, BRITISH COLUMBIA--(Marketwired - Oct. 24, 2014) - Premier Diagnostic Health Services Inc. ("Premier" or the "Company") (CSE:PDH) announces that it has issued a total of 9,196,885 Common shares following receipt of notices of warrant exercise from certain warrantholders of the Company. A total of 9,196,885 Common shares are issuable upon the exercise. All the warrantholders are insiders of the Company and are subject to a hold period expiring on February 25, 2015.

Following the exercise, Corner Market Capital Corp. ("CMCC"), an insider of the Company, indirectly owns and exercises control and direction over 45,707,935 Common shares of the Company, being 35.09% of the issued and outstanding Common shares on an undiluted basis. CMCC is a private company of which Sanjeev Parsad and Alnesh Mohan are majority shareholders and directors and officers. Mr. Parsad is the President, CEO and a director of Premier. Mr. Mohan is a director of Premier.

About Premier Diagnostic Health Services Inc. ("PDHS")

PDHS is a Canadian company that provides, through its subsidiaries, advanced medical diagnostic tools using PET/CT technology and/or MRI technology and related diagnostic skills in Canada and in the People's Republic of China, in partnership with local medical professionals, public and private investors, hospitals and clinics.

On behalf of the Board of Directors

Sanjeev Parsad President, CEO and Director

The Canadian Stock Exchange (CSE) has not reviewed the adequacy or the accuracy of the contents of this document. Company information can be viewed here: www.cnsx.ca. Further information regarding the Company can be found on SEDAR at ww.sedar.com. Not for dissemination in the United States of America.

Contact Information